The California stem cell agency is missing the essential point of complaints from the biotech industry concerning CIRM's record on funding commercial research.
In its response to the biotech concerns, CIRM parsed statistics compiled by BayBio, the biotech industry group in Northern California, but ignored the reason for the private dinner meeting in August between top executives of the $3 |
No comments:
Post a Comment